NIASPAN

Mark For: NIASPAN™ trademark registration is intended to cover the categories of pharmaceutical preparation for the treatment of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, and respiratory and infectious diseases. [all]

Status

2024-01-03 UTC
⟳ Refresh

DEAD APPLICATION Refused Dismissed or Invalidated

Research	OneLook Acronym Finder
Serial Number	76428724
Mark Literal Elements	NIASPAN
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	TMO LAW OFFICE 116 - DOCKET CLERK 2005-11-29
Basis	1(a)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	Yes
Current Use	Yes
Intent To Use	No
Filed ITU	No
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	KAREN P BECHTOLD
Law Office Assigned	M70
Employee Name	CARROLL, DORITT

Timeline

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical preparation for the treatment of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, and respiratory and infectious diseases. FIRST USE: 20020129. FIRST USE IN COMMERCE: 20020128(ABANDONED)
IC 016. US 002 005 022 023 029 037 038 050. G & S: printed materials, namely, brochures, pamphlets, leaflets, booklets, mailings and print advertisements in publications/magazines, featuring health information about and treatments for lipid disorders, arteriosclerosis, and cardiovascular diseases. FIRST USE: 20020129. FIRST USE IN COMMERCE: 20020128